Related Experiment Video
Updated: Jun 4, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
A comparative analysis of depression screening tools in multiple sclerosis: Implications for diagnosis and prevalence
Béatrice Degraeve1, Bruno Lenne2, Laurène Norberciak3
1Lille Catholic University, Lille, ETHICS (EA7446), France.
Background:
The BDI-II is still widely used to assess the importance of depressive symptoms in persons with MS (PwMS), despite recent recommendations to use a reduced and adapted form of this screening tool (BDI-FS).
Method:
We compared the prevalence of depressive symptoms in 329 PwMS which completed both the BDI-II and the BDI-FS and test the agreement between both screening tools.
Results:
The BDI-FS shows a lower overall prevalence of depression but not for severe cases.
Conclusion:
It is crucial to raise awareness about the potential implications of choosing either of these tools in the context of MS.
Related Concept Videos
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia

